As the world's largest and most broadly-based health care company, Johnson & Johnson recognizes the importance of stakeholder engagement. Our Credo, written more than 70 years ago, acknowledges the diversity of stakeholders to whom we are responsible, and is our guide to stakeholder engagement. We foster and maintain ties with the suppliers and external manufacturers who help us make our products; the customers who purchase our products; the doctors, nurses, patients and consumers who use them; and our own employees and shareholders. We routinely engage with civil society leaders in our efforts to advance our vision of health for humanity.

Stakeholder engagement occurs at all levels of the Company, from employees at our manufacturing sites to senior management in our business segments and functional departments, to our Johnson & Johnson Executive Committee and Board of Directors. Information gained through these interactions throughout the organization is communicated through line management, and as appropriate, to senior management. In addition, for certain stakeholder engagements related to key business segments and functions, we leverage a customer relationship management system to ensure a seamless process around engagements and information-capture. For more information, visit Corporate Governance. GRI 102-21

In determining with whom to engage, we take into consideration a variety of factors for ensuring the most optimal outcome. Some of these factors include: GRI 102-42

The possible alignment of our goals and values with that of the stakeholder group.

Our ability to improve human health, social, environmental and other outcomes because of this engagement.

The opportunity for mutual learning.

Our stakeholder engagements inform our business decisions, help us to set priorities that guide our business into the future, and help us to understand where our stakeholders think we can lead in addressing emerging societal needs. The level of our engagements spans from collaborations aimed at informing and knowledge exchange, to cooperation on local or targeted issues, and to strategic partnerships with a larger or longer-term focus and commitment.

In 2016, we conducted a refresh of our prior assessment last conducted in 2013/2014. See Our Priority Topics Assessment for more information. To find a matrix of the stakeholder groups we engage with, how we engage with them, select examples of 2016 engagements and examples of key memberships/associations, see below. For more information on our engagements on the front lines of care, see Global Community Impact page on our website.

expand

expand

GRI 102-40, 102-43, 102-44

expand

Following are select examples of our engagement with stakeholders in 2016.

Environmental Health:

C40: Johnson & Johnson partnered with the C40 Climate Leadership Group—a network of the world's 90 megacities that are committed to climate leadership and action -- to help fund programs that will link climate action with the benefits to air quality and human health.

RE100: RE100 is a collaborative, global initiative of influential businesses committed to 100 percent renewable electricity, working to massively increase demand for—and delivery of—renewable energy. Johnson & Johnson has set an RE100 target to power all of its facilities with renewable energy by 2050. We were the first health care company to join the ranks of other prominent businesses that have made this pledge. RE100 is led by The Climate Group in partnership with the CDP.

Medical Society Consortium on Climate and Health: Johnson & Johnson is a founding sponsor of the Consortium, a program of the George Mason University’s Center for Climate Change Communications (4C) that brings together medical associations representing 400,000 clinical practitioners to inform the public, health care community and policymakers about the harmful health effects of climate change.

Community Impact & Development:

Bush Center—Invictus Games on Invisible Wounds: Johnson & Johnson partnered with the Bush Institute to sponsor the W100, a 100-kilometer bike ride for our Wounded Warrior veterans, to enable rehabilitation through the promotion of physical health, recreation, and family strengthening.

Through a strategic partnership with Vital Voices, an organization that works with thousands of women leaders from over 140 countries, Johnson & Johnson is providing tailored support to a select group of 100 of the most engaged and visionary members of the Vital Voices Global Leadership Network to help them achieve their bold and innovative visions for changing their communities and countries. The effort included sharing of best practices across the network and problem-solving among network peers, as well as partnering with Vital Voices to galvanize the larger Global Leadership Network.

Women in Science, Technology, Engineering, Math, Manufacturing & Design: A partnership with the National Center for Women and Information Technology and nine leading academic centers around the world, founded by Johnson & Johnson to help increase the number of undergraduate women enrolling in and declaring majors in the fields of Science, Technology, Engineering, Math, Manufacturing and Design.

Coalition for Epidemic Preparedness Innovations: Partnership with the World Economic Forum, the Gates Foundation, the Wellcome Trust and the government of Norway, among other organizations, to form a unique public-private partnership with a goal of working together to help fast-track vaccine development for known pathogens before they pose an epidemic threat. In addition, Johnson & Johnson is an active participant in the Alliance for Biosecurity and No More Epidemics, both of which are also focused on pandemic preparedness.

Innovation:

Africa Innovation Challenge: A partnership designed to find and support Africa-based entrepreneurs who are developing creative health care products and services. The challenge is focused on three target areas: early child development and maternal health, empowering young girls, and overall family well-being.

Innovating Health for Tomorrow: A pioneering program that addresses the practical issues of innovation and change management for senior health care executives, helping them to re-think the challenges of aging populations, rising expectations and chronic illness, and to improve the efficiency of health provision.

HIV Viral Load Diagnostic: Announced a collaboration with the biotechnology company Cue to develop an HIV viral load test using Cue Lab-In-A-Box proprietary molecular diagnostics platform.

Externally developed economic, environmental and social charters, principles, and other initiatives to which we subscribe are included in the relevant sections of this report. GRI 102-12

expand

Johnson & Johnson participates with numerous non-governmental and advocacy organizations and industry associations on topics of interest to the Company. GRI 102-13

A list of select memberships and associations follows:

Advanced Medical Technology Association

Asia Pacific Medical Technology Association

Association for the Advancement of Medical Instrumentation

Biotechnology Industry Organization

BIO Ventures for Global Health

California Healthcare Institute

CDP

Children Without Worms

Closed Loop Fund

Consumer Goods Forum

Consumer Healthcare Products Association

Corporate EcoForum

Council of Supply Chain Manufacturing Professionals

Healthcare Businesswomen’s Association

HealthCare Institute of New Jersey

Healthcare Leadership Council

National Health Council

New Horizons Collaborative

New York University School of Medicine

Personal Care Products Council

Pharmaceutical Research and Manufacturers of America

Pharmaceutical Supply Chain Initiative

The Business Roundtable

The Conference Board

The Sustainability Consortium

United Nations

United Nations Global Compact

United Way

United States Agency for International Development

U.S. Chamber of Commerce

World Health Organization

Vital Voices

Participants at our Vital Voices VV100 launch event, kicking off a partnership to provide training and development to women from more than 140 countries who are at the forefront of change and global progress.

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.